Post by Novo Nordisk Foundation

Last month, we brought together experts and partners for our Global Science Summit to accelerate the understanding, prevention, and management of cardiometabolic diseases, a group of conditions that includes diabetes and heart disease. As the Summit drew to a close, we asked one final question: what single change could make the biggest difference in bending the curve on these diseases over the next five years?

Video Content